These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 16466921

  • 1. Ether derivatives of 3-piperidinopropan-1-ol as non-imidazole histamine H3 receptor antagonists.
    Łazewska D, Ligneau X, Schwartz JC, Schunack W, Stark H, Kieć-Kononowicz K.
    Bioorg Med Chem; 2006 May 15; 14(10):3522-9. PubMed ID: 16466921
    [Abstract] [Full Text] [Related]

  • 2. Piperidine variations in search for non-imidazole histamine H(3) receptor ligands.
    Łazewska D, Kuder K, Ligneau X, Schwartz JC, Schunack W, Stark H, Kieć-Kononowicz K.
    Bioorg Med Chem; 2008 Sep 15; 16(18):8729-36. PubMed ID: 18774720
    [Abstract] [Full Text] [Related]

  • 3. Structural variations of 1-(4-(phenoxymethyl)benzyl)piperidines as nonimidazole histamine H3 receptor antagonists.
    Mikó T, Ligneau X, Pertz HH, Arrang JM, Ganellin CR, Schwartz JC, Schunack W, Stark H.
    Bioorg Med Chem; 2004 May 15; 12(10):2727-36. PubMed ID: 15110854
    [Abstract] [Full Text] [Related]

  • 4. 4-Alkynylphenyl imidazolylpropyl ethers as selective histamine H3-receptor antagonists with high oral central nervous system activity.
    Krause M, Ligneau X, Stark H, Garbarg M, Schwartz JC, Schunack W.
    J Med Chem; 1998 Oct 08; 41(21):4171-6. PubMed ID: 9767653
    [Abstract] [Full Text] [Related]

  • 5. Diether derivatives of homo- or substituted piperidines as non-imidazole histamine H3 receptor ligands.
    Łazewska D, Kuder K, Ligneau X, Camelin JC, Schunack W, Stark H, Kieć-Kononowicz K.
    Bioorg Med Chem; 2009 Apr 15; 17(8):3037-42. PubMed ID: 19329325
    [Abstract] [Full Text] [Related]

  • 6. Novel nonimidazole histamine H3 receptor antagonists: 1-(4-(phenoxymethyl)benzyl)piperidines and related compounds.
    Mikó T, Ligneau X, Pertz HH, Ganellin CR, Arrang JM, Schwartz JC, Schunack W, Stark H.
    J Med Chem; 2003 Apr 10; 46(8):1523-30. PubMed ID: 12672253
    [Abstract] [Full Text] [Related]

  • 7. Piperidine-containing histamine H3 receptor antagonists of the carbamate series: the influence of the additional ether functionality.
    Łazewska D, Kieć-Kononowicz K, Pertz HH, Elz S, Stark H, Schunack W.
    Pharmazie; 2002 Dec 10; 57(12):791-5. PubMed ID: 12561236
    [Abstract] [Full Text] [Related]

  • 8. 4-(omega-(alkyloxy)alkyl)-1H-imidazole derivatives as histamine H(3) receptor antagonists/agonists.
    Meier G, Krause M, Hüls A, Ligneau X, Pertz HH, Arrang JM, Ganellin CR, Schwartz JC, Schunack W, Stark H.
    J Med Chem; 2004 May 06; 47(10):2678-87. PubMed ID: 15115409
    [Abstract] [Full Text] [Related]

  • 9. 4-phenoxypiperidines: potent, conformationally restricted, non-imidazole histamine H3 antagonists.
    Dvorak CA, Apodaca R, Barbier AJ, Berridge CW, Wilson SJ, Boggs JD, Xiao W, Lovenberg TW, Carruthers NI.
    J Med Chem; 2005 Mar 24; 48(6):2229-38. PubMed ID: 15771465
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Development of chiral N-alkylcarbamates as new leads for potent and selective H3-receptor antagonists: synthesis, capillary electrophoresis, and in vitro and oral in vivo activity.
    Sasse A, Kiec-Kononowicz K, Stark H, Motyl M, Reidemeister S, Ganellin CR, Ligneau X, Schwartz JC, Schunack W.
    J Med Chem; 1999 Feb 25; 42(4):593-600. PubMed ID: 10052966
    [Abstract] [Full Text] [Related]

  • 12. Synthesis and structure-activity relationships for biphenyl H3 receptor antagonists with moderate anti-cholinesterase activity.
    Morini G, Comini M, Rivara M, Rivara S, Bordi F, Plazzi PV, Flammini L, Saccani F, Bertoni S, Ballabeni V, Barocelli E, Mor M.
    Bioorg Med Chem; 2008 Dec 01; 16(23):9911-24. PubMed ID: 18976927
    [Abstract] [Full Text] [Related]

  • 13. Identification and pharmacological characterization of a series of new 1H-4-substituted-imidazoyl histamine H3 receptor ligands.
    Yates SL, Phillips JG, Gregory R, Pawlowski GP, Fadnis L, Khan MA, Ali SM, Tedford CE.
    J Pharmacol Exp Ther; 1999 May 01; 289(2):1151-9. PubMed ID: 10215699
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. New 1-benzyl-4-hydroxypiperidine derivatives as non-imidazole histamine H3 receptor antagonists.
    Maslowska-Lipowicz I, Figlus M, Zuiderveld OP, Walczynski K.
    Arch Pharm (Weinheim); 2008 Dec 01; 341(12):762-73. PubMed ID: 19009544
    [Abstract] [Full Text] [Related]

  • 16. Novel histamine H3 receptor antagonists based on the 4-[(1H-imidazol-4-yl)methyl]piperidine scaffold.
    Vaccaro WD, Sher R, Berlin M, Shih NY, Aslanian R, Schwerdt JH, McCormick KD, Piwinski JJ, West RE, Anthes JC, Williams SM, Wu RL, She HS, Rivelli MA, Mutter JC, Corboz MR, Hey JA, Favreau L.
    Bioorg Med Chem Lett; 2006 Jan 15; 16(2):395-9. PubMed ID: 16246552
    [Abstract] [Full Text] [Related]

  • 17. Replacement of imidazole by a piperidine moiety differentially affects the potency of histamine H3-receptor antagonists.
    Liedtke S, Flau K, Kathmann M, Schlicker E, Stark H, Meier G, Schunack W.
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Jan 15; 367(1):43-50. PubMed ID: 12616340
    [Abstract] [Full Text] [Related]

  • 18. A novel series of (phenoxyalkyl)imidazoles as potent H3-receptor histamine antagonists.
    Ganellin CR, Fkyerat A, Bang-Andersen B, Athmani S, Tertiuk W, Garbarg M, Ligneau X, Schwartz JC.
    J Med Chem; 1996 Sep 13; 39(19):3806-13. PubMed ID: 8809168
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Reduction of CYP450 inhibition in the 4-[(1H-imidazol-4-yl)methyl]piperidine series of histamine H3 receptor antagonists.
    Berlin M, Ting PC, Vaccaro WD, Aslanian R, McCormick KD, Lee JF, Albanese MM, Mutahi MW, Piwinski JJ, Shih NY, Duguma L, Solomon DM, Zhou W, Sher R, Favreau L, Bryant M, Korfmacher WA, Nardo C, West RE, Anthes JC, Williams SM, Wu RL, Susan She H, Rivelli MA, Corboz MR, Hey JA.
    Bioorg Med Chem Lett; 2006 Feb 15; 16(4):989-94. PubMed ID: 16297617
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.